Farms.com Home   News

Swine Health Information Center 2021 Plan of Work Focuses on Emerging Disease

The Executive Director of the Swine Health Information Center says the agency’s 2021 plan of work focuses primarily on the identification, prevention and response to emerging diseases. The Swine Health Information Center’s Plan of Work and operating budget for 2021 were approved by the SHIC Board of Directors at the end of January.
 
SHIC Executive Director Dr. Paul Sundberg explains the 2021 plan covers what needs to happen within the next 12 months and it's really focussed on how we address emerging diseases.
 
Clip-Dr. Paul Sundberg-Swine Health Information Center:
 
There are our endemic diseases, the PRRS, the Circoviruses, the Mycoplasmas, there's foreign animal diseases and in between that is, how can we address emerging diseases, number one find them, number two be prepared to respond if we can't prevent them, which should be the first thing.
 
If we don't prevent them, we have to prepared to respond and we have to offer for people data analysis and data mining of all of the things we know that are out there. We do address African Swine Fever in the 2020 report as well as in the 2021 plan of work. We do address PRRS in the 2021 plan of work but those are all within the idea of how we can build our infrastructure such that we're able to quickly detect and respond to emerging diseases.
 
In the 2021 plan of work for example, you see references to endemic diseases but that's all within for example how do we build biosecurity, how do we build response, what do we have to do to be able to effectively manage. All of those types of things can address endemic, foreign animal diseases, all within the light of how we are prepared to respond, prepared to prevent and prepared to work on emerging disease.
Source : Farmscape

Trending Video

A new era in biostimulants and bionutritionals

Video: A new era in biostimulants and bionutritionals


In response to the growing need for efficient, effective biosolutions, HGS BioScience continues to expand its footprint in the bionutritional and biostimulant market with the acquisition of NutriAg, Ltd. The Paine Schwartz Partners-backed HGS BioScience is a global leader in humic and fulvic acid products. Toronto-based NutriAg is an innovator in bionutritional technologies with a deep R&D engine. North American growers and retailers will benefit from:

• Solutions across the biostimulant spectrum - including humics, fulvics, bionutritionals, carbohydrate chelation, amino acids, plant and seaweed extracts, and microbial technologies.
• A portfolio and R&D pipeline of science-backed solutions proven to drive crop productivity and farm profitability.
• Actionable nutrient insights and recommendations based on data specific to their farm and cropping goals with the NutriAnalytics platform